Researchers at Genomics England, Genomic Medicine Centres, academic researchers and partners have access to data from cancer patients who took part in Cancer Pilots (lung, breast, colon, prostate, ovary and chronic lymphocytic leukaemia) within the 100,000 Genomes Project.
They will analyse the tumour genomes and compare them to an individual’s germline (non-tumour) genome.
They aim to improve our understanding of cancer biology.
They aim to identify changes to the genome that are causing cancer. They also aim to work out how this information might be used to benefit patients in the future.
This research group hope to produce summaries of clinical, genomic and pathological features to help uncover genomic drivers (causes) of cancer.
- June 22, 2016